Human hepatitis B virus X protein augments the DNA binding of nuclear factor for IL-6 through its basic-leucine zipper domain

Journal of Medical Virology

Volumn 58, Issue 1, 1999, Pages 11-18

  Ohno, Hideki ^a   Kaneko, Shuichi ^a   Lin, Yong ^a   Kobayashi, Kenichi ^a   Murakami, Seishi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

bZip; HBV; HBx; NF IL6

Indexed keywords

CIS ACTING ELEMENT; GENE PRODUCT; INTERLEUKIN 6; INTERLEUKIN 8; LEUCINE ZIPPER PROTEIN; NUCLEAR FACTOR; RECOMBINANT PROTEIN; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; DNA PROBE; GENE EXPRESSION; HEPATITIS B VIRUS; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION;

BINDING SITES; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTERLEUKIN-6; LEUCINE ZIPPERS; NF-KAPPA B; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATORS;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0032959637     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199905)58:1<11::AID-JMV2>3.0.CO;2-H     Document Type: Article

References (47)

1. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, Nakajima T, Hirano T, Kishimoto T. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9:1897-1906.
2. Akira S, Kishimoto T. 1992. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127:25-50.
3. Antunovic J, Lemieux N, Cromlish JA. 1993. The 17 kDa HBx protein encoded by hepatitis B virus interacts with the activation domains of Oct-1, and functions as a coactivator in the activation and repression of a human U6 promoter. Cell Mol Biol Res 39:463-482.
4. Aufiero B, Schneider RJ. 1990. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J 9:497-504.
5. Avantaggiati ML, Balsano C, Natoli G, De Marzio E, Will H, Elfassi E, Levrero M. 1992. The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factors. Arch Virol 4(suppl):57-61.
6. Baranger AM, Palmer CR, Hamm MK, Giebler HA, Brauweiler A, Nyborg JK, Schepartz A. 1995. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature 376:606-608.
7. Barnabas S, Hai T, Andrisani OM. 1997. The hepatitis B virus X protein enhances the DNA binding potential and transcription efficacy of bZip transcription factors. J Biol Chem 272:20684-20690.
8. Benn J, Schneider RJ. 1994. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Nat Acad Sci USA 91:10350-10354.
9. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
10. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH. 1993. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67:1218-1226.
11. Cheong JH, Yi M, Lin Y, Murakami S. 1995. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 14:143-150.
12. Faktor O, Budlovsky S, Ben LR, Shaul Y. 1990. A single element within the hepatitis B virus enhancer binds multiple proteins and responds to multiple stimuli. J Virol 64:1861-1863.
13. Feitelson M, Zhu M, Duan L, London W. 1993. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109-1117.
14. Haviv I, Vaizel D, Shaul Y. 1995. The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol 15:1079-1085.
15. Kaelin WG, Jr, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
16. Kakumu S, Shinagawa T, Ishikawa T, Yoshioka K, Wakita T, Ito Y, Takayanagi M, Ida N. 1991. Serum interleukin 6 levels in patients with chronic hepatitis B. Am J Gastroenterol 86:1804-1808.
17. Kakumu S, Fukatsu A, Shinagawa T, Kurokawa S, Kusakabe A. 1992. Localisation of intrahepatic interleukin 6 in patients with acute and chronic liver disease. J Clin Pathol 45:408-411.
18. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH. 1993. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742-745.
19. Kinoshita S, Akira S, Kishimoto T. 1992. A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6. Proc Nat Acad Sci USA 89:1473-1476.
20. Kodama K, Ogasawara N, Yoshikawa H, Murakami S. 1985. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J Virol 56:978-986.
21. Lee T, Elledge S, Butel J. 1995. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol 69:1107-1114.
22. Lin Y, Nomura T, Cheong J, Dorjsuren D, Iida K, Murakami S. 1997a. Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem 272:7132-7139.
23. Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S. 1997b. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res 57:5137-5142.
24. Lucito R, Schneider RJ. 1992. Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol 66:983-991.
25. Maguire HF, Hoeffler JP, Siddiqui A. 1991. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252:842-844.
26. Mane Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S. 1991. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. J Biol Chem 266:13759-13763.
27. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S. 1993. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Nat Acad Sci USA 90:10193-10197.
28. Miller RH, Kaneko S, Chung CT, Girones R, Purcell RH. 1989. Compact organization of the hepatitis B virus genome. Hepatology 9: 322-327.
29. Murakami S, Uchijima M, Shimoda A, Kaneko S, Kobayashi K, Hattori N. 1990. Hepadnavirus enhancer and its binding proteins. Gastroenterol Jpn 2(suppl 25):11-19.
30. Murakami S, Cheong J, Ohno S, Matsushima K, Kaneko S. 1994a. Transactivation of human hepatitis B virus X protein, HBx, operates through a mechanism distinct from protein kinase C and okadaic acid activation pathways. Virology 199:243-246.
31. Murakami S, Cheong JH, Kaneko S. 1994b. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 269:15118-15123.
32. Natoli G, Avantaggiati M, Chirillo P, Costanzo A, Artini M, Balsano C, Levrero M. 1994. Induction of the DNA-binding activity of c-jun/ c-fos heterodimers by the hepatitis B virus transactivator pX. Mol Cell Biol 14:989-998.
33. Ohno H, Kaneko S, Kobayashi K, Murakami S. 1997. Human hepatitis B virus enhancer 1 is responsive to human interleukin-6. J Med Virol 52:413-418.
34. Perini G, Wagner S, Green MR. 1995. Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax. Nature 376: 602-605.
35. Qadri I, Conaway JW, Conaway RC, Schaack J, Siddiqui A. 1996a. Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Nat Acad Sci USA 93:10578-10583.
36. Qadri I, Ferrari ME, Siddiqui A. 1996b. The hepatitis B virus trans-activator protein, HBx, interacts with single-stranded DNA (ssDNA): biochemical characterizations of the HBx-ssDNA interactions. J Biol Chem 271:15443-15450.
37. Seto E, Mitchell PJ, Yen TS. 1990. Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature 344:72-74.
38. Smith DB, Johnson KS. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
39. Takada S, Koike K. 1990. X protein of hepatitis B virus resembles a serine protease inhibitor. Jpn J Cancer Res 81:1191-1194.
40. Torre D, Zeroli C, Giola M, Ferrario G, Fiori GP, Bonetta G, Tambini R. 1994. Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Inf Dis 18:194-198.
41. Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish J. 1995. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol 69:1851-1859.
42. Twu JS, Lai MY, Chen DS, Robinson WS. 1993. Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology 192: 346-350.
43. Ueda H, Ullrich S, Gangemi J, Kappel C, Ngo L, Feitelson M, Jay G. 1995. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9:41-47.
44. Wagner S, Green MR. 1993. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262: 395-399.
45. Wang X, Forrester K, Yeh H, Feitelson M, Gu J, Harris C. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Nat Acad Sci USA 91:2230-2234.
46. Williams JS, Andrisani OM. 1995. The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Nat Acad Sci USA 92:3819-3823.
47. Zoulim F, Saputelli J, Seeger C. 1994. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68:2026-2030.